cfr_sections
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
84 rows where part_number = 111 and title_number = 21 sorted by section_id
This data as json, CSV (advanced)
Suggested facets: subpart, subpart_name, amendment_citations
| section_id ▼ | title_number | title_name | chapter | subchapter | part_number | part_name | subpart | subpart_name | section_number | section_heading | agency | authority | source_citation | amendment_citations | full_text |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21:21:2.0.1.1.11.1.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | A | Subpart A—General Provisions | § 111.1 Who is subject to this part? | FDA | (a) Except as provided by paragraph (b) of this section, you are subject to this part if you manufacture, package, label, or hold a dietary supplement, including: (1) A dietary supplement you manufacture but that is packaged or labeled by another person; and (2) A dietary supplement imported or offered for import in any State or territory of the United States, the District of Columbia, or the Commonwealth of Puerto Rico. (b) The requirements pertaining to holding dietary supplements do not apply to you if you are holding those dietary supplements at a retail establishment for the sole purpose of direct retail sale to individual consumers. A retail establishment does not include a warehouse or other storage facility for a retailer or a warehouse or other storage facility that sells directly to individual consumers. | ||||
| 21:21:2.0.1.1.11.1.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | A | Subpart A—General Provisions | § 111.3 What definitions apply to this part? | FDA | The definitions and interpretations of terms in section 201 of the Federal Food, Drug, and Cosmetic Act (the act) apply to such terms when used in this part. For the purpose of this part, the following definitions also apply: Actual yield means the quantity that is actually produced at any appropriate step of manufacture or packaging of a particular dietary supplement. Batch means a specific quantity of a dietary supplement that is uniform, that is intended to meet specifications for identity, purity, strength, and composition, and that is produced during a specified time period according to a single manufacturing record during the same cycle of manufacture. Batch number, lot number, or control number means any distinctive group of letters, numbers, or symbols, or any combination of them, from which the complete history of the manufacturing, packaging, labeling, and/or holding of a batch or lot of dietary supplements can be determined. Component means any substance intended for use in the manufacture of a dietary supplement, including those that may not appear in the finished batch of the dietary supplement. Component includes dietary ingredients (as described in section 201(ff) of the act) and other ingredients. Contact surface means any surface that contacts a component or dietary supplement, and those surfaces from which drainage onto the component or dietary supplement, or onto surfaces that contact the component or dietary supplement, occurs during the normal course of operations. Examples of contact surfaces include containers, utensils, tables, contact surfaces of equipment, and packaging. Ingredient means any substance that is used in the manufacture of a dietary supplement and that is intended to be present in the finished batch of the dietary supplement. An ingredient includes, but is not necessarily limited to, a dietary ingredient as defined in section 201(ff) of the act. In-process material means any material that is fabricated, compounded, blended, ground, extracted, sifted, sterilized… | ||||
| 21:21:2.0.1.1.11.1.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | A | Subpart A—General Provisions | § 111.5 Do other statutory provisions and regulations apply? | FDA | [72 FR 34942, June 25, 2007, as amended at 80 FR 74352, Nov. 27, 2015] | In addition to this part, you must comply with other applicable statutory provisions and regulations under the act related to dietary supplements. For importers of dietary supplements and dietary supplement components, the regulation on foreign supplier verification programs can be found in subpart L of part 1 of this chapter. | |||
| 21:21:2.0.1.1.11.10.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | J | Subpart J—Production and Process Control System: Requirements for Laboratory Operations | § 111.303 What are the requirements under this subpart J for written procedures? | FDA | You must establish and follow written procedures for laboratory operations, including written procedures for the tests and examinations that you conduct to determine whether specifications are met. | ||||
| 21:21:2.0.1.1.11.10.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | J | Subpart J—Production and Process Control System: Requirements for Laboratory Operations | § 111.310 What are the requirements for the laboratory facilities that you use? | FDA | You must use adequate laboratory facilities to perform whatever testing and examinations are necessary to determine whether: (a) Components that you use meet specifications; (b) In-process specifications are met as specified in the master manufacturing record; and (c) Dietary supplements that you manufacture meet specifications. | ||||
| 21:21:2.0.1.1.11.10.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | J | Subpart J—Production and Process Control System: Requirements for Laboratory Operations | § 111.315 What are the requirements for laboratory control processes? | FDA | You must establish and follow laboratory control processes that are reviewed and approved by quality control personnel, including the following: (a) Use of criteria for establishing appropriate specifications; (b) Use of sampling plans for obtaining representative samples, in accordance with subpart E of this part, of: (1) Components, packaging, and labels; (2) In-process materials; (3) Finished batches of dietary supplements; (4) Product that you receive for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier); and (5) Packaged and labeled dietary supplements. (c) Use of criteria for selecting appropriate examination and testing methods; (d) Use of criteria for selecting standard reference materials used in performing tests and examinations; and (e) Use of test methods and examinations in accordance with established criteria. | ||||
| 21:21:2.0.1.1.11.10.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | J | Subpart J—Production and Process Control System: Requirements for Laboratory Operations | § 111.320 What requirements apply to laboratory methods for testing and examination? | FDA | (a) You must verify that the laboratory examination and testing methodologies are appropriate for their intended use. (b) You must identify and use an appropriate scientifically valid method for each established specification for which testing or examination is required to determine whether the specification is met. | ||||
| 21:21:2.0.1.1.11.10.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | J | Subpart J—Production and Process Control System: Requirements for Laboratory Operations | § 111.325 Under this subpart J, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart J in accordance with subpart P of this part. (b) You must make and keep the following records: (1) Written procedures for laboratory operations, including written procedures for the tests and examinations that you conduct to determine whether specifications are met; (2) Documentation that laboratory methodology established in accordance with this subpart J is followed. (i) The person who conducts the testing and examination must document, at the time of performance, that laboratory methodology established in accordance with this subpart J is followed. (ii) The documentation for laboratory tests and examinations must include the results of the testing and examination. | ||||
| 21:21:2.0.1.1.11.11.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | K | Subpart K—Production and Process Control System: Requirements for Manufacturing Operations | § 111.353 What are the requirements under this subpart K for written procedures? | FDA | You must establish and follow written procedures for manufacturing operations. | ||||
| 21:21:2.0.1.1.11.11.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | K | Subpart K—Production and Process Control System: Requirements for Manufacturing Operations | § 111.355 What are the design requirements for manufacturing operations? | FDA | You must design or select manufacturing processes to ensure that product specifications are consistently met. | ||||
| 21:21:2.0.1.1.11.11.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | K | Subpart K—Production and Process Control System: Requirements for Manufacturing Operations | § 111.360 What are the requirements for sanitation? | FDA | You must conduct all manufacturing operations in accordance with adequate sanitation principles. | ||||
| 21:21:2.0.1.1.11.11.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | K | Subpart K—Production and Process Control System: Requirements for Manufacturing Operations | § 111.365 What precautions must you take to prevent contamination? | FDA | You must take all the necessary precautions during the manufacture of a dietary supplement to prevent contamination of components or dietary supplements. These precautions include: (a) Performing manufacturing operations under conditions and controls that protect against the potential for growth of microorganisms and the potential for contamination; (b) Washing or cleaning components that contain soil or other contaminants; (c) Using water that, at a minimum, complies with the applicable Federal, State, and local requirements and does not contaminate the dietary supplement when the water may become a component of the finished batch of dietary supplement; (d) Performing chemical, microbiological, or other testing, as necessary to prevent the use of contaminated components; (e) Sterilizing, pasteurizing, freezing, refrigerating, controlling hydrogen-ion concentration (pH), controlling humidity, controlling water activity (a w ), or using any other effective means to remove, destroy, or prevent the growth of microorganisms and prevent decomposition; (f) Holding components and dietary supplements that can support the rapid growth of microorganisms of public health significance in a manner that prevents the components and dietary supplements from becoming adulterated; (g) Identifying and holding any components or dietary supplements, for which a material review and disposition decision is required, in a manner that protects components or dietary supplements that are not under a material review against contamination and mixups with those that are under a material review; (h) Performing mechanical manufacturing steps (such as cutting, sorting, inspecting, shredding, drying, grinding, blending, and sifting) by any effective means to protect the dietary supplements against contamination, by, for example: (1) Cleaning and sanitizing contact surfaces; (2) Using temperature controls; and (3) Using time controls. (i) Using effective measures to protect against the inclusion of metal or other foreign material in co… | ||||
| 21:21:2.0.1.1.11.11.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | K | Subpart K—Production and Process Control System: Requirements for Manufacturing Operations | § 111.370 What requirements apply to rejected dietary supplements? | FDA | You must clearly identify, hold, and control under a quarantine system for appropriate disposition any dietary supplement that is rejected and unsuitable for use in manufacturing, packaging, or labeling operations. | ||||
| 21:21:2.0.1.1.11.11.1.6 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | K | Subpart K—Production and Process Control System: Requirements for Manufacturing Operations | § 111.375 Under this subpart K, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart K in accordance with subpart P of this part. (b) You must make and keep records of the written procedures for manufacturing operations. | ||||
| 21:21:2.0.1.1.11.12.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | L | Subpart L—Production and Process Control System: Requirements for Packaging and Labeling Operations | § 111.403 What are the requirements under this subpart L for written procedures? | FDA | You must establish and follow written procedures for packaging and labeling operations. | ||||
| 21:21:2.0.1.1.11.12.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | L | Subpart L—Production and Process Control System: Requirements for Packaging and Labeling Operations | § 111.410 What requirements apply to packaging and labels? | FDA | (a) You must take necessary actions to determine whether packaging for dietary supplements meets specifications so that the condition of the packaging will ensure the quality of your dietary supplements; (b) You must control the issuance and use of packaging and labels and reconciliation of any issuance and use discrepancies. Label reconciliation is not required for cut or rolled labels if a 100-percent examination for correct labels is performed by appropriate electronic or electromechanical equipment during or after completion of finishing operations; and (c) You must examine, before packaging and labeling operations, packaging and labels for each batch of dietary supplement to determine whether the packaging and labels conform to the master manufacturing record; and (d) You must be able to determine the complete manufacturing history and control of the packaged and labeled dietary supplement through distribution. | ||||
| 21:21:2.0.1.1.11.12.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | L | Subpart L—Production and Process Control System: Requirements for Packaging and Labeling Operations | § 111.415 What requirements apply to filling, assembling, packaging, labeling, and related operations? | FDA | You must fill, assemble, package, label, and perform other related operations in a way that ensures the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record. You must do this using any effective means, including the following: (a) Cleaning and sanitizing all filling and packaging equipment, utensils, and dietary supplement packaging, as appropriate; (b) Protecting manufactured dietary supplements from contamination, particularly airborne contamination; (c) Using sanitary handling procedures; (d) Establishing physical or spatial separation of packaging and label operations from operations on other components and dietary supplements to prevent mixups; (e) Identifying, by any effective means, filled dietary supplement containers that are set aside and held in unlabeled condition for future label operations, to prevent mixups; (f) Assigning a batch, lot, or control number to: (1) Each lot of packaged and labeled dietary supplement from a finished batch of dietary supplement; and, (2) Each lot of dietary supplement, from a finished batch of dietary supplement, that you distribute to another person for packaging or labeling. (g) Examining a representative sample of each batch of the packaged and labeled dietary supplement to determine whether the dietary supplement meets specifications established in accordance with § 111.70(g); and (h) Suitably disposing of labels and packaging for dietary supplements that are obsolete or incorrect to ensure that they are not used in any future packaging and label operations. | ||||
| 21:21:2.0.1.1.11.12.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | L | Subpart L—Production and Process Control System: Requirements for Packaging and Labeling Operations | § 111.420 What requirements apply to repackaging and relabeling? | FDA | (a) You may repackage or relabel dietary supplements only after quality control personnel have approved such repackaging or relabeling. (b) You must examine a representative sample of each batch of repackaged or relabeled dietary supplements to determine whether the repackaged or relabeled dietary supplements meet all specifications established in accordance with § 111.70(g). (c) Quality control personnel must approve or reject each batch of repackaged or relabeled dietary supplement prior to its release for distribution. | ||||
| 21:21:2.0.1.1.11.12.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | L | Subpart L—Production and Process Control System: Requirements for Packaging and Labeling Operations | § 111.425 What requirements apply to a packaged and labeled dietary supplement that is rejected for distribution? | FDA | You must clearly identify, hold, and control under a quarantine system for appropriate disposition any packaged and labeled dietary supplement that is rejected for distribution. | ||||
| 21:21:2.0.1.1.11.12.1.6 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | L | Subpart L—Production and Process Control System: Requirements for Packaging and Labeling Operations | § 111.430 Under this subpart L, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart L in accordance with subpart P of this part. (b) You must make and keep records of the written procedures for packaging and labeling operations. | ||||
| 21:21:2.0.1.1.11.13.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | M | Subpart M—Holding and Distributing | § 111.453 What are the requirements under this subpart for M written procedures? | FDA | You must establish and follow written procedures for holding and distributing operations. | ||||
| 21:21:2.0.1.1.11.13.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | M | Subpart M—Holding and Distributing | § 111.455 What requirements apply to holding components, dietary supplements, packaging, and labels? | FDA | (a) You must hold components and dietary supplements under appropriate conditions of temperature, humidity, and light so that the identity, purity, strength, and composition of the components and dietary supplements are not affected. (b) You must hold packaging and labels under appropriate conditions so that the packaging and labels are not adversely affected. (c) You must hold components, dietary supplements, packaging, and labels under conditions that do not lead to the mixup, contamination, or deterioration of components, dietary supplements, packaging, and labels. | ||||
| 21:21:2.0.1.1.11.13.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | M | Subpart M—Holding and Distributing | § 111.460 What requirements apply to holding in-process material? | FDA | (a) You must identify and hold in-process material under conditions that protect against mixup, contamination, and deterioration. (b) You must hold in-process material under appropriate conditions of temperature, humidity, and light. | ||||
| 21:21:2.0.1.1.11.13.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | M | Subpart M—Holding and Distributing | § 111.465 What requirements apply to holding reserve samples of dietary supplements? | FDA | (a) You must hold reserve samples of dietary supplements in a manner that protects against contamination and deterioration. This includes: (1) Holding the reserve samples under conditions consistent with product labels or, if no storage conditions are recommended on the label, under ordinary storage conditions; and (2) Using the same container-closure system in which the packaged and labeled dietary supplement is distributed, or if distributing dietary supplements to be packaged and labeled, using a container-closure system that provides essentially the same characteristics to protect against contamination or deterioration as the one in which you distribute the dietary supplement for packaging and labeling elsewhere. (b) You must retain reserve samples for 1 year past the shelf life date (if shelf life dating is used), or for 2 years from the date of distribution of the last batch of dietary supplements associated with the reserve samples, for use in appropriate investigations. | ||||
| 21:21:2.0.1.1.11.13.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | M | Subpart M—Holding and Distributing | § 111.470 What requirements apply to distributing dietary supplements? | FDA | You must distribute dietary supplements under conditions that will protect the dietary supplements against contamination and deterioration. | ||||
| 21:21:2.0.1.1.11.13.1.6 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | M | Subpart M—Holding and Distributing | § 111.475 Under this subpart M, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart M in accordance with subpart P of this part. (b) You must make and keep the following records: (1) Written procedures for holding and distributing operations; and (2) Records of product distribution. | ||||
| 21:21:2.0.1.1.11.14.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | N | Subpart N—Returned Dietary Supplements | § 111.503 What are the requirements under this subpart N for written procedures? | FDA | You must establish and follow written procedures to fulfill the requirements of this subpart. | ||||
| 21:21:2.0.1.1.11.14.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | N | Subpart N—Returned Dietary Supplements | § 111.510 What requirements apply when a returned dietary supplement is received? | FDA | You must identify and quarantine returned dietary supplements until quality control personnel conduct a material review and make a disposition decision. | ||||
| 21:21:2.0.1.1.11.14.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | N | Subpart N—Returned Dietary Supplements | § 111.515 When must a returned dietary supplement be destroyed, or otherwise suitably disposed of? | FDA | You must destroy, or otherwise suitably dispose of, any returned dietary supplement unless the outcome of a material review and disposition decision is that quality control personnel do the following: (a) Approve the salvage of the returned dietary supplement for redistribution or (b) Approve the returned dietary supplement for reprocessing. | ||||
| 21:21:2.0.1.1.11.14.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | N | Subpart N—Returned Dietary Supplements | § 111.520 When may a returned dietary supplement be salvaged? | FDA | You may salvage a returned dietary supplement only if quality control personnel conduct a material review and make a disposition decision to allow the salvage. | ||||
| 21:21:2.0.1.1.11.14.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | N | Subpart N—Returned Dietary Supplements | § 111.525 What requirements apply to a returned dietary supplement that quality control personnel approve for reprocessing? | FDA | (a) You must ensure that any returned dietary supplements that are reprocessed meet all product specifications established in accordance with § 111.70(e); and (b) Quality control personnel must approve or reject the release for distribution of any returned dietary supplement that is reprocessed. | ||||
| 21:21:2.0.1.1.11.14.1.6 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | N | Subpart N—Returned Dietary Supplements | § 111.530 When must an investigation be conducted of your manufacturing processes and other batches? | FDA | If the reason for a dietary supplement being returned implicates other batches, you must conduct an investigation of your manufacturing processes and each of those other batches to determine compliance with specifications. | ||||
| 21:21:2.0.1.1.11.14.1.7 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | N | Subpart N—Returned Dietary Supplements | § 111.535 Under this subpart N, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart N in accordance with subpart P of this part. (b) You must make and keep the following records: (1) Written procedures for fulfilling the requirements of this subpart N. (2) Any material review and disposition decision on a returned dietary supplement; (3) The results of any testing or examination conducted to determine compliance with product specifications established under § 111.70(e); and, (4) Documentation of the reevaluation by quality control personnel of any dietary supplement that is reprocessed and the determination by quality control personnel of whether the reprocessed dietary supplement meets product specifications established in accordance with § 111.70(e). | ||||
| 21:21:2.0.1.1.11.15.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | O | Subpart O—Product Complaints | § 111.553 What are the requirements under this subpart O for written procedures? | FDA | You must establish and follow written procedures to fulfill the requirements of this subpart O. | ||||
| 21:21:2.0.1.1.11.15.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | O | Subpart O—Product Complaints | § 111.560 What requirements apply to the review and investigation of a product complaint? | FDA | (a) A qualified person must: (1) Review all product complaints to determine whether the product complaint involves a possible failure of a dietary supplement to meet any of its specifications, or any other requirements of this part 111, including those specifications and other requirements that, if not met, may result in a risk of illness or injury; and (2) Investigate any product complaint that involves a possible failure of a dietary supplement to meet any of its specifications, or any other requirements of this part, including those specifications and other requirements that, if not met, may result in a risk of illness or injury. (b) Quality control personnel must review and approve decisions about whether to investigate a product complaint and review and approve the findings and followup action of any investigation performed. (c) The review and investigation of the product complaint by a qualified person, and the review by quality control personnel about whether to investigate a product complaint, and the findings and followup action of any investigation performed, must extend to all relevant batches and records. | ||||
| 21:21:2.0.1.1.11.15.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | O | Subpart O—Product Complaints | § 111.570 Under this subpart O, what records must you make and keep? | FDA | (a) You must make and keep the records required under this subpart O in accordance with subpart P of this part. (b) You must make and keep the following records: (1) Written procedures for fulfilling the requirements of this subpart, (2) A written record of every product complaint that is related to good manufacturing practice, (i) The person who performs the requirements of this subpart must document, at the time of performance, that the requirement was performed. (ii) The written record of the product complaint must include the following: (A) The name and description of the dietary supplement; (B) The batch, lot, or control number of the dietary supplement, if available; (C) The date the complaint was received and the name, address, or telephone number of the complainant, if available; (D) The nature of the complaint including, if known, how the product was used; (E) The reply to the complainant, if any; and (F) Findings of the investigation and followup action taken when an investigation is performed. | ||||
| 21:21:2.0.1.1.11.16.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | P | Subpart P—Records and Recordkeeping | § 111.605 What requirements apply to the records that you make and keep? | FDA | (a) You must keep written records required by this part for 1 year past the shelf life date, if shelf life dating is used, or 2 years beyond the date of distribution of the last batch of dietary supplements associated with those records. (b) Records must be kept as original records, as true copies (such as photocopies, microfilm, microfiche, or other accurate reproductions of the original records), or as electronic records. (c) All electronic records must comply with part 11 of this chapter. | ||||
| 21:21:2.0.1.1.11.16.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | P | Subpart P—Records and Recordkeeping | § 111.610 What records must be made available to FDA? | FDA | (a) You must have all records required under this part, or copies of such records, readily available during the retention period for inspection and copying by FDA when requested. (b) If you use reduction techniques, such as microfilming, you must make suitable reader and photocopying equipment readily available to FDA. | ||||
| 21:21:2.0.1.1.11.2.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | B | Subpart B—Personnel | § 111.8 What are the requirements under this subpart B for written procedures? | FDA | You must establish and follow written procedures for fulfilling the requirements of this subpart. | ||||
| 21:21:2.0.1.1.11.2.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | B | Subpart B—Personnel | § 111.10 What requirements apply for preventing microbial contamination from sick or infected personnel and for hygienic practices? | FDA | (a) Preventing microbial contamination. You must take measures to exclude from any operations any person who might be a source of microbial contamination, due to a health condition, where such contamination may occur, of any material, including components, dietary supplements, and contact surfaces used in the manufacture, packaging, labeling, or holding of a dietary supplement. Such measures include the following: (1) Excluding from working in any operations that may result in contamination any person who, by medical examination, the person's acknowledgement, or supervisory observation, is shown to have, or appears to have, an illness, infection, open lesion, or any other abnormal source of microbial contamination, that could result in microbial contamination of components, dietary supplements, or contact surfaces, until the health condition no longer exists; and (2) Instructing your employees to notify their supervisor(s) if they have or if there is a reasonable possibility that they have a health condition described in paragraph (a)(1) of this section that could result in microbial contamination of any components, dietary supplements, or any contact surface. (b) Hygienic practices. If you work in an operation during which adulteration of the component, dietary supplement, or contact surface could occur, you must use hygienic practices to the extent necessary to protect against such contamination of components, dietary supplements, or contact surfaces. These hygienic practices include the following: (1) Wearing outer garments in a manner that protects against the contamination of components, dietary supplements, or any contact surface; (2) Maintaining adequate personal cleanliness; (3) Washing hands thoroughly (and sanitizing if necessary to protect against contamination with microorganisms) in an adequate hand-washing facility: (i) Before starting work; and (ii) At any time when the hands may have become soiled or contaminated; (4) Removing all unsecured jewelry and other objects that might fall in… | ||||
| 21:21:2.0.1.1.11.2.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | B | Subpart B—Personnel | § 111.12 What personnel qualification requirements apply? | FDA | (a) You must have qualified employees who manufacture, package, label, or hold dietary supplements. (b) You must identify who is responsible for your quality control operations. Each person who is identified to perform quality control operations must be qualified to do so and have distinct and separate responsibilities related to performing such operations from those responsibilities that the person otherwise has when not performing such operations. (c) Each person engaged in manufacturing, packaging, labeling, or holding, or in performing any quality control operations, must have the education, training, or experience to perform the person's assigned functions. | ||||
| 21:21:2.0.1.1.11.2.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | B | Subpart B—Personnel | § 111.13 What supervisor requirements apply? | FDA | (a) You must assign qualified personnel to supervise the manufacturing, packaging, labeling, or holding of dietary supplements. (b) Each supervisor whom you use must be qualified by education, training, or experience to supervise. | ||||
| 21:21:2.0.1.1.11.2.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | B | Subpart B—Personnel | § 111.14 Under this subpart B, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart B in accordance with subpart P of this part. (b) You must make and keep the following records: (1) Written procedures for fulfilling the requirements of this subpart B; and (2) Documentation of training, including the date of the training, the type of training, and the person(s) trained. | ||||
| 21:21:2.0.1.1.11.3.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | C | Subpart C—Physical Plant and Grounds | § 111.15 What sanitation requirements apply to your physical plant and grounds? | FDA | (a) Grounds. You must keep the grounds of your physical plant in a condition that protects against the contamination of components, dietary supplements, or contact surfaces. The methods for adequate ground maintenance include: (1) Properly storing equipment, removing litter and waste, and cutting weeds or grass within the immediate vicinity of the physical plant so that it does not attract pests, harbor pests, or provide pests a place for breeding; (2) Maintaining roads, yards, and parking lots so that they do not constitute a source of contamination in areas where components, dietary supplements, or contact surfaces are exposed; (3) Adequately draining areas that may contribute to the contamination of components, dietary supplements, or contact surfaces by seepage, filth or any other extraneous materials, or by providing a breeding place for pests; (4) Adequately operating systems for waste treatment and disposal so that they do not constitute a source of contamination in areas where components, dietary supplements, or contact surfaces are exposed; and (5) If your plant grounds are bordered by grounds not under your control, and if those other grounds are not maintained in the manner described in this section, you must exercise care in the plant by inspection, extermination, or other means to exclude pests, dirt, and filth or any other extraneous materials that may be a source of contamination. (b) Physical plant facilities. (1) You must maintain your physical plant in a clean and sanitary condition; and (2) You must maintain your physical plant in repair sufficient to prevent components, dietary supplements, or contact surfaces from becoming contaminated. (c) Cleaning compounds, sanitizing agents, pesticides, and other toxic materials. (1) You must use cleaning compounds and sanitizing agents that are free from microorganisms of public health significance and that are safe and adequate under the conditions of use. (2) You must not use or hold toxic materials in a physical plant in which component… | ||||
| 21:21:2.0.1.1.11.3.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | C | Subpart C—Physical Plant and Grounds | § 111.16 What are the requirements under this subpart C for written procedures? | FDA | You must establish and follow written procedures for cleaning the physical plant and for pest control. | ||||
| 21:21:2.0.1.1.11.3.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | C | Subpart C—Physical Plant and Grounds | § 111.20 What design and construction requirements apply to your physical plant? | FDA | Any physical plant you use in the manufacture, packaging, labeling, or holding of dietary supplements must: (a) Be suitable in size, construction, and design to facilitate maintenance, cleaning, and sanitizing operations; (b) Have adequate space for the orderly placement of equipment and holding of materials as is necessary for maintenance, cleaning, and sanitizing operations and to prevent contamination and mixups of components and dietary supplements during manufacturing, packaging, labeling, or holding; (c) Permit the use of proper precautions to reduce the potential for mixups or contamination of components, dietary supplements, or contact surfaces, with microorganisms, chemicals, filth, or other extraneous material. Your physical plant must have, and you must use, separate or defined areas of adequate size or other control systems, such as computerized inventory controls or automated systems of separation, to prevent contamination and mixups of components and dietary supplements during the following operations: (1) Receiving, identifying, holding, and withholding from use, components, dietary supplements, packaging, and labels that will be used in or during the manufacturing, packaging, labeling, or holding of dietary supplements; (2) Separating, as necessary, components, dietary supplements, packaging, and labels that are to be used in manufacturing from components, dietary supplements, packaging, or labels that are awaiting material review and disposition decision, reprocessing, or are awaiting disposal after rejection; (3) Separating the manufacturing, packaging, labeling, and holding of different product types including different types of dietary supplements and other foods, cosmetics, and pharmaceutical products; (4) Performing laboratory analyses and holding laboratory supplies and samples; (5) Cleaning and sanitizing contact surfaces; (6) Packaging and label operations; and (7) Holding components or dietary supplements. (d) Be designed and constructed in a manner that prevents contamination… | ||||
| 21:21:2.0.1.1.11.3.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | C | Subpart C—Physical Plant and Grounds | § 111.23 Under this subpart C, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart C in accordance with subpart P of this part. (b) You must make and keep records of the written procedures for cleaning the physical plant and for pest control. (c) You must make and keep records that show that water, when used in a manner such that the water may become a component of the dietary supplement, meets the requirements of § 111.15(e)(2). | ||||
| 21:21:2.0.1.1.11.4.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | D | Subpart D—Equipment and Utensils | § 111.25 What are the requirements under this subpart D for written procedures? | FDA | You must establish and follow written procedures for fulfilling the requirements of this subpart D, including written procedures for: (a) Calibrating instruments and controls that you use in manufacturing or testing a component or dietary supplement; (b) Calibrating, inspecting, and checking automated, mechanical, and electronic equipment; and (c) Maintaining, cleaning, and sanitizing, as necessary, all equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements. | ||||
| 21:21:2.0.1.1.11.4.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | D | Subpart D—Equipment and Utensils | § 111.27 What requirements apply to the equipment and utensils that you use? | FDA | [72 FR 34942, June 25, 2007, as amended at 73 FR 13124, Mar. 12, 2008] | (a) You must use equipment and utensils that are of appropriate design, construction, and workmanship to enable them to be suitable for their intended use and to be adequately cleaned and properly maintained. (1) Equipment and utensils include the following: (i) Equipment used to hold or convey; (ii) Equipment used to measure; (iii) Equipment using compressed air or gas; (iv) Equipment used to carry out processes in closed pipes and vessels; and (v) Equipment used in automated, mechanical, or electronic systems. (2) You must use equipment and utensils of appropriate design and construction so that use will not result in the contamination of components or dietary supplements with: (i) Lubricants; (ii) Fuel; (iii) Coolants; (iv) Metal or glass fragments; (v) Filth or any other extraneous material; (vi) Contaminated water; or (vii) Any other contaminants. (3) All equipment and utensils you use must be: (i) Installed and maintained to facilitate cleaning the equipment, utensils, and all adjacent spaces; (ii) Corrosion-resistant if the equipment or utensils contact components or dietary supplements; (iii) Made of nontoxic materials; (iv) Designed and constructed to withstand the environment in which they are used, the action of components or dietary supplements, and, if applicable, cleaning compounds and sanitizing agents; and (v) Maintained to protect components and dietary supplements from being contaminated by any source. (4) Equipment and utensils you use must have seams that are smoothly bonded or maintained to minimize accumulation of dirt, filth, organic material, particles of components or dietary supplements, or any other extraneous materials or contaminants. (5) Each freezer, refrigerator, and other cold storage compartment you use to hold components or dietary supplements: (i) Must be fitted with an indicating thermometer, temperature-measuring device, or temperature-recording device that indicates and records, or allows for recording by hand, the temperature accurately within the com… | |||
| 21:21:2.0.1.1.11.4.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | D | Subpart D—Equipment and Utensils | § 111.30 What requirements apply to automated, mechanical, or electronic equipment? | FDA | For any automated, mechanical, or electronic equipment that you use to manufacture, package, label, or hold a dietary supplement, you must: (a) Design or select equipment to ensure that dietary supplement specifications are consistently met; (b) Determine the suitability of the equipment by ensuring that your equipment is capable of operating satisfactorily within the operating limits required by the process; (c) Routinely calibrate, inspect, or check the equipment to ensure proper performance. Your quality control personnel must periodically review these calibrations, inspections, or checks; (d) Establish and use appropriate controls for automated, mechanical, and electronic equipment (including software for a computer controlled process) to ensure that any changes to the manufacturing, packaging, labeling, holding, or other operations are approved by quality control personnel and instituted only by authorized personnel; and (e) Establish and use appropriate controls to ensure that the equipment functions in accordance with its intended use. These controls must be approved by quality control personnel. | ||||
| 21:21:2.0.1.1.11.4.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | D | Subpart D—Equipment and Utensils | § 111.35 Under this subpart D, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart D in accordance with subpart P of this part. (b) You must make and keep the following records: (1) Written procedures for fulfilling the requirements of this subpart, including written procedures for: (i) Calibrating instruments and controls that you use in manufacturing or testing a component or dietary supplement; (ii) Calibrating, inspecting, and checking automated, mechanical, and electronic equipment; and (iii) Maintaining, cleaning, and sanitizing, as necessary, all equipment, utensils, and any other contact surfaces that are used to manufacture, package, label, or hold components or dietary supplements; (2) Documentation, in individual equipment logs, of the date of the use, maintenance, cleaning, and sanitizing of equipment, unless such documentation is kept with the batch record; (3) Documentation of any calibration, each time the calibration is performed, for instruments and controls that you use in manufacturing or testing a component or dietary supplement. In your documentation, you must: (i) Identify the instrument or control calibrated; (ii) Provide the date of calibration; (iii) Identify the reference standard used including the certification of accuracy of the known reference standard and a history of recertification of accuracy; (iv) Identify the calibration method used, including appropriate limits for accuracy and precision of instruments and controls when calibrating; (v) Provide the calibration reading or readings found; (vi) Identify the recalibration method used, and reading or readings found, if accuracy or precision or both accuracy and precision limits for instruments and controls were not met; and (vii) Include the initials of the person who performed the calibration and any recalibration. (4) Written records of calibrations, inspections, and checks of automated, mechanical, and electronic equipment; (5) Backup file(s) of current software programs (and of outdated software that is necessary to retrieve record… | ||||
| 21:21:2.0.1.1.11.5.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.55 What are the requirements to implement a production and process control system? | FDA | You must implement a system of production and process controls that covers all stages of manufacturing, packaging, labeling, and holding of the dietary supplement to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record. | ||||
| 21:21:2.0.1.1.11.5.1.10 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.87 Who conducts a material review and makes a disposition decision? | FDA | Quality control personnel must conduct all required material reviews and make all required disposition decisions. | ||||
| 21:21:2.0.1.1.11.5.1.11 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.90 What requirements apply to treatments, in-process adjustments, and reprocessing when there is a deviation or unanticipated occurrence or when a specification established in accordance with § 111.70 is not met? | FDA | (a) You must not reprocess a rejected dietary supplement or treat or provide an in-process adjustment to a component, packaging, or label to make it suitable for use in the manufacture of a dietary supplement unless: (1) Quality control personnel conduct a material review and make a disposition decision to approve the reprocessing, treatment, or in-process adjustment; and (2) The reprocessing, treatment, or in-process adjustment is permitted by § 111.77; (b) You must not reprocess any dietary supplement or treat or provide an in-process adjustment to a component to make it suitable for use in the manufacture of a dietary supplement, unless: (1) Quality control personnel conduct a material review and make a disposition decision that is based on a scientifically valid reason and approves the reprocessing, treatment, or in-process adjustment; and (2) The reprocessing, treatment or in-process adjustment is permitted by § 111.77; (c) Any batch of dietary supplement that is reprocessed, that contains components that you have treated, or to which you have made in-process adjustments to make them suitable for use in the manufacture of the dietary supplement must be approved by quality control personnel and comply with § 111.123(b) before releasing for distribution. | ||||
| 21:21:2.0.1.1.11.5.1.12 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.95 Under this subpart E, what records must you make and keep? | FDA | [72 FR 34942, June 25, 2007, as amended at 72 FR 34968, June 25, 2007] | (a) You must make and keep records required under this subpart E in accordance with subpart P of this part. (b) Under this subpart E, you must make and keep the following records: (1) The specifications established; (2) Documentation of your qualification of a supplier for the purpose of relying on the supplier's certificate of analysis; (3) Documentation for why meeting in-process specifications, in combination with meeting component specifications, helps ensure that the dietary supplement meets the specifications for identity, purity, strength, and composition; and for limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch of the dietary supplement; and (4) Documentation for why the results of appropriate tests or examinations for the product specifications selected under § 111.75(c)(1) ensure that the dietary supplement meets all product specifications; (5) Documentation for why any component and in-process testing, examination, or monitoring, and any other information, will ensure that a product specification that is exempted under § 111.75(d) is met without verification through periodic testing of the finished batch, including documentation that the selected specifications tested or examined under § 111.75 (c)(1) are not able to verify that the production and process control system is producing a dietary supplement that meets the exempted product specification and there is no scientifically valid method for testing or examining such exempted product specification at the finished batch stage. (6) Documentation of FDA's response to a petition submitted under § 111.75(a)(1)(ii) providing for an exemption from the provisions of § 111.75(a)(1)(i). | |||
| 21:21:2.0.1.1.11.5.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.60 What are the design requirements for the production and process control system? | FDA | (a) Your production and in-process control system must be designed to ensure that the dietary supplement is manufactured, packaged, labeled, and held in a manner that will ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record; and (b) The production and in-process control system must include all requirements of subparts E through L of this part and must be reviewed and approved by quality control personnel. | ||||
| 21:21:2.0.1.1.11.5.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.65 What are the requirements for quality control operations? | FDA | You must implement quality control operations in your manufacturing, packaging, labeling, and holding operations for producing the dietary supplement to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record. | ||||
| 21:21:2.0.1.1.11.5.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.70 What specifications must you establish? | FDA | (a) You must establish a specification for any point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record. (b) For each component that you use in the manufacture of a dietary supplement, you must establish component specifications as follows: (1) You must establish an identity specification; (2) You must establish component specifications that are necessary to ensure that specifications for the purity, strength and composition of dietary supplements manufactured using the components are met; and (3) You must establish limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch of the dietary supplement to ensure the quality of the dietary supplement. (c) For the in-process production: (1) You must establish in-process specifications for any point, step, or stage in the master manufacturing record where control is necessary to help ensure that specifications are met for the identity, purity, strength, and composition of the dietary supplements and, as necessary, for limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch of the dietary supplement; (2) You must provide adequate documentation of your basis for why meeting the in-process specifications, in combination with meeting component specifications, will help ensure that the specifications are met for the identity, purity, strength, and composition of the dietary supplements and for limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch of the dietary supplement; and (3) Quality control personnel must review and approve the documentation that you provide under paragraph (c)(2) of this section. (d) You must establish specifications for dietary supplement labels (label specifications) and for packaging that may come in contact with … | ||||
| 21:21:2.0.1.1.11.5.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.73 What is your responsibility for determining whether established specifications are met? | FDA | You must determine whether the specifications you establish under § 111.70 are met. | ||||
| 21:21:2.0.1.1.11.5.1.6 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.75 What must you do to determine whether specifications are met? | FDA | [72 FR 34942, June 25, 2007, as amended at 72 FR 34968, June 25, 2007; 73 FR 27727, May 14, 2008] | (a) Before you use a component, you must: (1)(i) Conduct at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless you petition the agency under paragraph (a)(1)(ii) of this section and the agency exempts you from such testing; (ii) You may submit a petition, under 21 CFR 10.30, to request an exemption from the testing requirements in paragraph (a)(1)(i) of this section. The petition must set forth the scientific rationale, and must be accompanied by the supporting data and information, for proposed alternative testing that will demonstrate that there is no material diminution of assurance, compared to the assurance provided by 100 percent identity testing, of the identity of the dietary ingredient before use when the dietary ingredient is obtained from one or more suppliers identified in the petition. If FDA grants the petition, you must conduct the tests and examinations for the dietary ingredient, otherwise required under § 111.75(a)(1)(i), under the terms specified by FDA when the petition is granted; and (2) Confirm the identity of other components and determine whether other applicable component specifications established in accordance with § 111.70(b) are met. To do so, you must either: (i) Conduct appropriate tests or examinations; or (ii) Rely on a certificate of analysis from the supplier of the component that you receive, provided that: (A) You first qualify the supplier by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of the supplier's tests or examinations; (B) The certificate of analysis includes a description of the test or examination method(s) used, limits of the test or examinations, and actual results of the tests or examinations; (C) You maintain documentation of how you qualified the supplier; (D) You periodically re-confirm the supplier's certificate of analysis; and (E) Your quality control personnel review and approve the documentation setting forth the bas… | |||
| 21:21:2.0.1.1.11.5.1.7 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.77 What must you do if established specifications are not met? | FDA | (a) For specifications established under § 111.70(a), (b)(2), (b)(3), (c), (d), (e), and (g) that you do not meet, quality control personnel, in accordance with the requirements in subpart F of this part, must reject the component, dietary supplement, package or label unless such personnel approve a treatment, an in-process adjustment, or reprocessing that will ensure the quality of the finished dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record. No finished batch of dietary supplements may be released for distribution unless it complies with § 111.123(b). (b) For specifications established under § 111.70(b)(1) that you do not meet, quality control personnel must reject the component and the component must not be used in manufacturing the dietary supplement. (c) For specifications established under § 111.70(f) that you do not meet, quality control personnel must reject the product and the product may not be packaged or labeled for distribution as a dietary supplement. | ||||
| 21:21:2.0.1.1.11.5.1.8 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.80 What representative samples must you collect? | FDA | The representative samples that you must collect include: (a) Representative samples of each unique lot of components, packaging, and labels that you use to determine whether the components, packaging, and labels meet specifications established in accordance with § 111.70(b) and (d), and as applicable, § 111.70(a) (and, when you receive components, packaging, or labels from a supplier, representative samples of each unique shipment, and of each unique lot within each unique shipment); (b) Representative samples of in-process materials for each manufactured batch at points, steps, or stages, in the manufacturing process as specified in the master manufacturing record where control is necessary to ensure the identity, purity, strength, and composition of dietary supplements to determine whether the in-process materials meet specifications established in accordance with § 111.70(c), and as applicable, § 111.70(a); (c) Representative samples of a subset of finished batches of each dietary supplement that you manufacture, which you identify through a sound statistical sampling plan (or otherwise every finished batch), before releasing for distribution to verify that the finished batch of dietary supplement meets product specifications established in accordance with § 111.70(e), and as applicable, § 111.70(a); (d) Representative samples of each unique shipment, and of each unique lot within each unique shipment, of product that you receive for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier) to determine whether the received product meets specifications established in accordance with § 111.70(f), and as applicable, § 111.70(a); and (e) Representative samples of each lot of packaged and labeled dietary supplements to determine whether the packaging and labeling of the finished packaged and labeled dietary supplements meet specifications established in accordance with § 111.70(g), and as applicable, § 111.70(a). | ||||
| 21:21:2.0.1.1.11.5.1.9 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | E | Subpart E—Requirement to Establish a Production and Process Control System | § 111.83 What are the requirements for reserve samples? | FDA | (a) You must collect and hold reserve samples of each lot of packaged and labeled dietary supplements that you distribute. (b) The reserve samples must: (1) Be held using the same container-closure system in which the packaged and labeled dietary supplement is distributed, or if distributing dietary supplements to be packaged and labeled, using a container-closure system that provides essentially the same characteristics to protect against contamination or deterioration as the one in which it is distributed for packaging and labeling elsewhere; (2) Be identified with the batch, lot, or control number; (3) Be retained for 1 year past the shelf life date (if shelf life dating is used), or for 2 years from the date of distribution of the last batch of dietary supplements associated with the reserve sample, for use in appropriate investigations; and (4) Consist of at least twice the quantity necessary for all tests or examinations to determine whether or not the dietary supplement meets product specifications. | ||||
| 21:21:2.0.1.1.11.6.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.103 What are the requirements under this subpart F for written procedures? | FDA | You must establish and follow written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision, and for approving or rejecting any reprocessing. | ||||
| 21:21:2.0.1.1.11.6.1.10 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.135 What quality control operations are required for product complaints? | FDA | Quality control operations for product complaints must include reviewing and approving decisions about whether to investigate a product complaint and reviewing and approving the findings and followup action of any investigation performed. | ||||
| 21:21:2.0.1.1.11.6.1.11 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.140 Under this subpart F, what records must you make and keep? | FDA | (a) You must make and keep the records required under this subpart F in accordance with subpart P of this part. (b) You must make and keep the following records: (1) Written procedures for the responsibilities of the quality control operations, including written procedures for conducting a material review and making a disposition decision and written procedures for approving or rejecting any reprocessing; (2) Written documentation, at the time of performance, that quality control personnel performed the review, approval, or rejection requirements by recording the following: (i) Date that the review, approval, or rejection was performed; and (ii) Signature of the person performing the review, approval, or rejection; and (3) Documentation of any material review and disposition decision and followup. Such documentation must be included in the appropriate batch production record and must include: (i) Identification of the specific deviation or the unanticipated occurrence; (ii) Description of your investigation into the cause of the deviation from the specification or the unanticipated occurrence; (iii) Evaluation of whether or not the deviation or unanticipated occurrence has resulted in or could lead to a failure to ensure the quality of the dietary supplement or a failure to package and label the dietary supplement as specified in the master manufacturing record; (iv) Identification of the action(s) taken to correct, and prevent a recurrence of, the deviation or the unanticipated occurrence; (v) Explanation of what you did with the component, dietary supplement, packaging, or label; (vi) A scientifically valid reason for any reprocessing of a dietary supplement that is rejected or any treatment or in-process adjustment of a component that is rejected; and (vii) The signature of the individual(s) designated to perform the quality control operation, who conducted the material review and made the disposition decision, and of each qualified individual who provides information relevant to that material rev… | ||||
| 21:21:2.0.1.1.11.6.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.105 What must quality control personnel do? | FDA | Quality control personnel must ensure that your manufacturing, packaging, labeling, and holding operations ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record. To do so, quality control personnel must perform operations that include: (a) Approving or rejecting all processes, specifications, written procedures, controls, tests, and examinations, and deviations from or modifications to them, that may affect the identity, purity, strength, or composition of a dietary supplement; (b) Reviewing and approving the documentation setting forth the basis for qualification of any supplier; (c) Reviewing and approving the documentation setting forth the basis for why meeting in-process specifications, in combination with meeting component specifications, will help ensure that the identity, purity, strength, and composition of the dietary supplement are met; (d) Reviewing and approving the documentation setting forth the basis for why the results of appropriate tests or examinations for each product specification selected under § 111.75(c)(1) will ensure that the finished batch of the dietary supplement meets product specifications; (e) Reviewing and approving the basis and the documentation for why any product specification is exempted from the verification requirements in § 111.75(c)(1), and for why any component and in-process testing, examination, or monitoring, or other methods will ensure that such exempted product specification is met without verification through periodic testing of the finished batch; (f) Ensuring that required representative samples are collected; (g) Ensuring that required reserve samples are collected and held; (h) Determining whether all specifications established under § 111.70(a) are met; and (i) Performing other operations required under this subpart. | ||||
| 21:21:2.0.1.1.11.6.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.110 What quality control operations are required for laboratory operations associated with the production and process control system? | FDA | Quality control operations for laboratory operations associated with the production and process control system must include: (a) Reviewing and approving all laboratory control processes associated with the production and process control system; (b) Ensuring that all tests and examinations required under § 111.75 are conducted; and (c) Reviewing and approving the results of all tests and examinations required under § 111.75. | ||||
| 21:21:2.0.1.1.11.6.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.113 What quality control operations are required for a material review and disposition decision? | FDA | (a) Quality control personnel must conduct a material review and make a disposition decision if: (1) A specification established in accordance with § 111.70 is not met; (2) A batch deviates from the master manufacturing record, including when any step established in the master manufacturing record is not completed and including any deviation from specifications; (3) There is any unanticipated occurrence during the manufacturing operations that adulterates or may lead to adulteration of the component, dietary supplement, or packaging, or could lead to the use of a label not specified in the master manufacturing record; (4) Calibration of an instrument or control suggests a problem that may have resulted in a failure to ensure the quality of a batch or batches of a dietary supplement; or (5) A dietary supplement is returned. (b)(1) When there is a deviation or unanticipated occurrence during the production and in-process control system that results in or could lead to adulteration of a component, dietary supplement, or packaging, or could lead to the use of a label not specified in the master manufacturing record, quality control personnel must reject the component, dietary supplement, packaging, or label unless it approves a treatment, an in-process adjustment, or reprocessing to correct the applicable deviation or occurrence. (2) When a specification established in accordance with § 111.70 is not met, quality control personnel must reject the component, dietary supplement, package or label, unless quality control personnel approve a treatment, an in-process adjustment, or reprocessing, as permitted in § 111.77. (c) The person who conducts a material review and makes the disposition decision must, at the time of performance, document that material review and disposition decision. | ||||
| 21:21:2.0.1.1.11.6.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.117 What quality control operations are required for equipment, instruments, and controls? | FDA | Quality control operations for equipment, instruments, and controls must include: (a) Reviewing and approving all processes for calibrating instruments and controls; (b) Periodically reviewing all records for calibration of instruments and controls; (c) Periodically reviewing all records for calibrations, inspections, and checks of automated, mechanical, or electronic equipment; and (d) Reviewing and approving controls to ensure that automated, mechanical, or electronic equipment functions in accordance with its intended use. | ||||
| 21:21:2.0.1.1.11.6.1.6 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.120 What quality control operations are required for components, packaging, and labels before use in the manufacture of a dietary supplement? | FDA | Quality control operations for components, packaging, and labels before use in the manufacture of a dietary supplement must include: (a) Reviewing all receiving records for components, packaging, and labels; (b) Determining whether all components, packaging, and labels conform to specifications established under § 111.70 (b) and (d); (c) Conducting any required material review and making any required disposition decision; (d) Approving or rejecting any treatment and in-process adjustments of components, packaging, or labels to make them suitable for use in the manufacture of a dietary supplement; and (e) Approving, and releasing from quarantine, all components, packaging, and labels before they are used. | ||||
| 21:21:2.0.1.1.11.6.1.7 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.123 What quality control operations are required for the master manufacturing record, the batch production record, and manufacturing operations? | FDA | (a) Quality control operations for the master manufacturing record, the batch production record, and manufacturing operations must include: (1) Reviewing and approving all master manufacturing records and all modifications to the master manufacturing records; (2) Reviewing and approving all batch production-related records; (3) Reviewing all monitoring required under subpart E; (4) Conducting any required material review and making any required disposition decision; (5) Approving or rejecting any reprocessing; (6) Determining whether all in-process specifications established in accordance with § 111.70(c) are met; (7) Determining whether each finished batch conforms to product specifications established in accordance with § 111.70(e); and (8) Approving and releasing, or rejecting, each finished batch for distribution, including any reprocessed finished batch. (b) Quality control personnel must not approve and release for distribution: (1) Any batch of dietary supplement for which any component in the batch does not meet its identity specification; (2) Any batch of dietary supplement, including any reprocessed batch, that does not meet all product specifications established in accordance with § 111.70(e); (3) Any batch of dietary supplement, including any reprocessed batch, that has not been manufactured, packaged, labeled, and held under conditions to prevent adulteration under section 402(a)(1), (a)(2), (a)(3), and (a)(4) of the act; and (4) Any product received from a supplier for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier) for which sufficient assurance is not provided to adequately identify the product and to determine that the product is consistent with your purchase order. | ||||
| 21:21:2.0.1.1.11.6.1.8 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.127 What quality control operations are required for packaging and labeling operations? | FDA | Quality control operations for packaging and labeling operations must include: (a) Reviewing the results of any visual examination and documentation to ensure that specifications established under § 111.70(f) are met for all products that you receive for packaging and labeling as a dietary supplement (and for distribution rather than for return to the supplier); (b) Approving, and releasing from quarantine, all products that you receive for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier) before they are used for packaging or labeling; (c) Reviewing and approving all records for packaging and label operations; (d) Determining whether the finished packaged and labeled dietary supplement conforms to specifications established in accordance with § 111.70(g); (e) Conducting any required material review and making any required disposition decision; (f) Approving or rejecting any repackaging of a packaged dietary supplement; (g) Approving or rejecting any relabeling of a packaged and labeled dietary supplement; and (h) Approving for release, or rejecting, any packaged and labeled dietary supplement (including a repackaged or relabeled dietary supplement) for distribution. | ||||
| 21:21:2.0.1.1.11.6.1.9 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | F | Subpart F—Production and Process Control System: Requirements for Quality Control | § 111.130 What quality control operations are required for returned dietary supplements? | FDA | Quality control operations for returned dietary supplements must include: (a) Conducting any required material review and making any required disposition decision; including: (1) Determining whether tests or examination are necessary to determine compliance with product specifications established in accordance with § 111.70(e); and (2) Reviewing the results of any tests or examinations that are conducted to determine compliance with product specifications established in accordance with § 111.70(e); (b) Approving or rejecting any salvage and redistribution of any returned dietary supplement; (c) Approving or rejecting any reprocessing of any returned dietary supplement; and (d) Determining whether the reprocessed dietary supplement meets product specifications and either approving for release, or rejecting, any returned dietary supplement that is reprocessed. | ||||
| 21:21:2.0.1.1.11.7.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | G | Subpart G—Production and Process Control System: Requirements for Components, Packaging, and Labels and for Product That You Receive for Packaging or Labeling as a Dietary Supplement | § 111.153 What are the requirements under this subpart G for written procedures? | FDA | You must establish and follow written procedures for fulfilling the requirements of this subpart G. | ||||
| 21:21:2.0.1.1.11.7.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | G | Subpart G—Production and Process Control System: Requirements for Components, Packaging, and Labels and for Product That You Receive for Packaging or Labeling as a Dietary Supplement | § 111.155 What requirements apply to components of dietary supplements? | FDA | (a) You must visually examine each immediate container or grouping of immediate containers in a shipment that you receive for appropriate content label, container damage, or broken seals to determine whether the container condition may have resulted in contamination or deterioration of the components; (b) You must visually examine the supplier's invoice, guarantee, or certification in a shipment you receive to ensure the components are consistent with your purchase order; (c) You must quarantine components before you use them in the manufacture of a dietary supplement until: (1) You collect representative samples of each unique lot of components (and, for components that you receive, of each unique shipment, and of each unique lot within each unique shipment); (2) Quality control personnel review and approve the results of any tests or examinations conducted on components; and (3) Quality control personnel approve the components for use in the manufacture of a dietary supplement, including approval of any treatment (including in-process adjustments) of components to make them suitable for use in the manufacture of a dietary supplement, and releases them from quarantine. (d)(1) You must identify each unique lot within each unique shipment of components that you receive and any lot of components that you produce in a manner that allows you to trace the lot to the supplier, the date received, the name of the component, the status of the component (e.g., quarantined, approved, or rejected); and to the dietary supplement that you manufactured and distributed. (2) You must use this unique identifier whenever you record the disposition of each unique lot within each unique shipment of components that you receive and any lot of components that you produce. (e) You must hold components under conditions that will protect against contamination and deterioration, and avoid mixups. | ||||
| 21:21:2.0.1.1.11.7.1.3 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | G | Subpart G—Production and Process Control System: Requirements for Components, Packaging, and Labels and for Product That You Receive for Packaging or Labeling as a Dietary Supplement | § 111.160 What requirements apply to packaging and labels received? | FDA | (a) You must visually examine each immediate container or grouping of immediate containers in a shipment for appropriate content label, container damage, or broken seals to determine whether the container condition may have resulted in contamination or deterioration of the packaging and labels. (b) You must visually examine the supplier's invoice, guarantee, or certification in a shipment to ensure that the packaging or labels are consistent with your purchase order. (c) You must quarantine packaging and labels before you use them in the manufacture of a dietary supplement until: (1) You collect representative samples of each unique shipment, and of each unique lot within each unique shipment, of packaging and labels and, at a minimum, conduct a visual identification of the immediate containers and closures; (2) Quality control personnel review and approve the results of any tests or examinations conducted on the packaging and labels; and (3) Quality control personnel approve the packaging and labels for use in the manufacture of a dietary supplement and release them from quarantine. (d)(1) You must identify each unique lot within each unique shipment of packaging and labels in a manner that allows you to trace the lot to the supplier, the date received, the name of the packaging and label, the status of the packaging and label (e.g., quarantined, approved, or rejected); and to the dietary supplement that you distributed; and (2) You must use this unique identifier whenever you record the disposition of each unique lot within each unique shipment of packaging and labels. (e) You must hold packaging and labels under conditions that will protect against contamination and deterioration, and avoid mixups. | ||||
| 21:21:2.0.1.1.11.7.1.4 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | G | Subpart G—Production and Process Control System: Requirements for Components, Packaging, and Labels and for Product That You Receive for Packaging or Labeling as a Dietary Supplement | § 111.165 What requirements apply to a product received for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier)? | FDA | (a) You must visually examine each immediate container or grouping of immediate containers in a shipment of product that you receive for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier) for appropriate content label, container damage, or broken seals to determine whether the container condition may have resulted in contamination or deterioration of the received product. (b) You must visually examine the supplier's invoice, guarantee, or certification in a shipment of the received product to ensure that the received product is consistent with your purchase order. (c) You must quarantine the received product until: (1) You collect representative samples of each unique shipment, and of each unique lot within each unique shipment, of received product; (2) Quality control personnel review and approve the documentation to determine whether the received product meets the specifications that you established under § 111.70(f); and (3) Quality control personnel approve the received product for packaging or labeling as a dietary supplement and release the received product from quarantine. (d)(1) You must identify each unique lot within each unique shipment of received product in a manner that allows you to trace the lot to the supplier, the date received, the name of the received product, the status of the received product (e.g., quarantined, approved, or rejected), and to the product that you packaged or labeled and distributed as a dietary supplement. (2) You must use this unique identifier whenever you record the disposition of each unique lot within each unique shipment of the received product. (e) You must hold the received product under conditions that will protect against contamination and deterioration, and avoid mixups. | ||||
| 21:21:2.0.1.1.11.7.1.5 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | G | Subpart G—Production and Process Control System: Requirements for Components, Packaging, and Labels and for Product That You Receive for Packaging or Labeling as a Dietary Supplement | § 111.170 What requirements apply to rejected components, packaging, and labels, and to rejected products that are received for packaging or labeling as a dietary supplement? | FDA | You must clearly identify, hold, and control under a quarantine system for appropriate disposition any component, packaging, and label, and any product that you receive for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier), that is rejected and unsuitable for use in manufacturing, packaging, or labeling operations. | ||||
| 21:21:2.0.1.1.11.7.1.6 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | G | Subpart G—Production and Process Control System: Requirements for Components, Packaging, and Labels and for Product That You Receive for Packaging or Labeling as a Dietary Supplement | § 111.180 Under this subpart G, what records must you make and keep? | FDA | (a) You must make and keep records required under this subpart G in accordance with subpart P of this part. (b) You must make and keep the following records: (1) Written procedures for fulfilling the requirements of this subpart. (2) Receiving records (including records such as certificates of analysis, suppliers' invoices, and suppliers' guarantees) for components, packaging, and labels and for products that you receive for packaging or labeling as a dietary supplement (and for distribution rather than for return to the supplier); and (3) Documentation that the requirements of this subpart were met. (i) The person who performs the required operation must document, at the time of performance, that the required operation was performed. (ii) The documentation must include: (A) The date that the components, packaging, labels, or products that you receive for packaging or labeling as a dietary supplement were received; (B) The initials of the person performing the required operation; (C) The results of any tests or examinations conducted on components, packaging, or labels, and of any visual examination of product that you receive for packaging or labeling as a dietary supplement; and (D) Any material review and disposition decision conducted on components, packaging, labels, or products that you receive for packaging or labeling as a dietary supplement. | ||||
| 21:21:2.0.1.1.11.8.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | H | Subpart H—Production and Process Control System: Requirements for the Master Manufacturing Record | § 111.205 What is the requirement to establish a master manufacturing record? | FDA | (a) You must prepare and follow a written master manufacturing record for each unique formulation of dietary supplement that you manufacture, and for each batch size, to ensure uniformity in the finished batch from batch to batch. (b) The master manufacturing record must: (1) Identify specifications for the points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record; and (2) Establish controls and procedures to ensure that each batch of dietary supplement that you manufacture meets the specifications identified in accordance with paragraph (b)(1) of this section. (c) You must make and keep master manufacturing records in accordance with subpart P of this part. | ||||
| 21:21:2.0.1.1.11.8.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | H | Subpart H—Production and Process Control System: Requirements for the Master Manufacturing Record | § 111.210 What must the master manufacturing record include? | FDA | The master manufacturing record must include: (a) The name of the dietary supplement to be manufactured and the strength, concentration, weight, or measure of each dietary ingredient for each batch size; (b) A complete list of components to be used; (c) An accurate statement of the weight or measure of each component to be used; (d) The identity and weight or measure of each dietary ingredient that will be declared on the Supplement Facts label and the identity of each ingredient that will be declared on the ingredients list of the dietary supplement; (e) A statement of any intentional overage amount of a dietary ingredient; (f) A statement of theoretical yield of a manufactured dietary supplement expected at each point, step, or stage of the manufacturing process where control is needed to ensure the quality of the dietary supplement, and the expected yield when you finish manufacturing the dietary supplement, including the maximum and minimum percentages of theoretical yield beyond which a deviation investigation of a batch is necessary and material review is conducted and disposition decision is made; (g) A description of packaging and a representative label, or a cross-reference to the physical location of the actual or representative label; (h) Written instructions, including the following: (1) Specifications for each point, step, or stage in the manufacturing process where control is necessary to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record; (2) Procedures for sampling and a cross-reference to procedures for tests or examinations; (3) Specific actions necessary to perform and verify points, steps, or stages in the manufacturing process where control is necessary to ensure the quality of the dietary supplement and that the dietary supplement is packaged and labeled as specified in the master manufacturing record. (i) Such specific actions must include verifying the weight or measure of any comp… | ||||
| 21:21:2.0.1.1.11.9.1.1 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | I | Subpart I—Production and Process Control System: Requirements for the Batch Production Record | § 111.255 What is the requirement to establish a batch production record? | FDA | (a) You must prepare a batch production record every time you manufacture a batch of a dietary supplement; (b) Your batch production record must include complete information relating to the production and control of each batch; (c) Your batch production record must accurately follow the appropriate master manufacturing record and you must perform each step in the production of the batch; and (d) You must make and keep batch production records in accordance with subpart P of this part. | ||||
| 21:21:2.0.1.1.11.9.1.2 | 21 | Food and Drugs | I | B | 111 | PART 111—CURRENT GOOD MANUFACTURING PRACTICE IN MANUFACTURING, PACKAGING, LABELING, OR HOLDING OPERATIONS FOR DIETARY SUPPLEMENTS | I | Subpart I—Production and Process Control System: Requirements for the Batch Production Record | § 111.260 What must the batch record include? | FDA | The batch production record must include the following: (a) The batch, lot, or control number: (1) Of the finished batch of dietary supplement; and (2) That you assign in accordance with § 111.415(f) for the following: (i) Each lot of packaged and labeled dietary supplement from the finished batch of dietary supplement; (ii) Each lot of dietary supplement, from the finished batch of dietary supplement, that you distribute to another person for packaging or labeling; (b) The identity of equipment and processing lines used in producing the batch; (c) The date and time of the maintenance, cleaning, and sanitizing of the equipment and processing lines used in producing the batch, or a cross-reference to records, such as individual equipment logs, where this information is retained; (d) The unique identifier that you assigned to each component (or, when applicable, to a product that you receive from a supplier for packaging or labeling as a dietary supplement), packaging, and label used; (e) The identity and weight or measure of each component used; (f) A statement of the actual yield and a statement of the percentage of theoretical yield at appropriate phases of processing; (g) The actual results obtained during any monitoring operation; (h) The results of any testing or examination performed during the batch production, or a cross-reference to such results; (i) Documentation that the finished dietary supplement meets specifications established in accordance with § 111.70(e) and (g); (j) Documentation, at the time of performance, of the manufacture of the batch, including: (1) The date on which each step of the master manufacturing record was performed; and (2) The initials of the persons performing each step, including: (i) The initials of the person responsible for weighing or measuring each component used in the batch; (ii) The initials of the person responsible for verifying the weight or measure of each component used in the batch; (iii) The initials of the person responsible for adding the co… |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE cfr_sections (
section_id TEXT PRIMARY KEY,
title_number INTEGER,
title_name TEXT,
chapter TEXT,
subchapter TEXT,
part_number TEXT,
part_name TEXT,
subpart TEXT,
subpart_name TEXT,
section_number TEXT,
section_heading TEXT,
agency TEXT,
authority TEXT,
source_citation TEXT,
amendment_citations TEXT,
full_text TEXT
);
CREATE INDEX idx_cfr_title ON cfr_sections(title_number);
CREATE INDEX idx_cfr_part ON cfr_sections(part_number);
CREATE INDEX idx_cfr_agency ON cfr_sections(agency);